<?xml version="1.0" encoding="UTF-8"?>
<ref id="B22-medicines-07-00057">
 <label>22.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Huestis</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Solimini</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Pichini</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pacifici</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Carlier</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Busard√≤</surname>
    <given-names>F.P.</given-names>
   </name>
  </person-group>
  <article-title>Cannabidiol Adverse Effects and Toxicity</article-title>
  <source>Curr. Neuropharmacol.</source>
  <year>2019</year>
  <volume>17</volume>
  <fpage>974</fpage>
  <lpage>989</lpage>
  <pub-id pub-id-type="doi">10.2174/1570159X17666190603171901</pub-id>
  <?supplied-pmid 31161980?>
  <pub-id pub-id-type="pmid">31161980</pub-id>
 </element-citation>
</ref>
